Quoin Pharmaceuticals (QNRX)

• Market cap: $6.23M
• 1 day: -8.58%
• 5 days: -22.21%
• 1 month: 43.47%
• 3 months: 54.18%
• 6 months: 63.97%
• Year to date: -56.04%
• 1 year: -58.96%
• 5 years: -99.97%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Employees: 3